Literature DB >> 21445433

Generator-based PET radiopharmaceuticals for molecular imaging of tumours: on the way to THERANOSTICS.

Frank Rösch1, Richard P Baum.   

Abstract

Generator-derived radionuclides for PET/CT imaging are promising for optimizing targeted radiotherapy by an individual patient-based approach, applying pre-therapeutic evaluation, as well as dosimetric calculations, and for measuring treatment response after radionuclide therapy.

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 21445433     DOI： 10.1039/c0dt01504k

Source DB:  PubMed          Journal:  Dalton Trans        ISSN： 1477-9226            Impact factor:   4.390


  34 in total

Review 1.  Somatostatin receptor PET ligands - the next generation for clinical practice.

Authors:  Elin Pauwels; Frederik Cleeren; Guy Bormans; Christophe M Deroose
Journal:  Am J Nucl Med Mol Imaging       Date:  2018-10-20

Review 2.  Feasibility and availability of ⁶⁸Ga-labelled peptides.

Authors:  Clemens Decristoforo; Roger D Pickett; Alfons Verbruggen
Journal:  Eur J Nucl Med Mol Imaging       Date:  2012-02       Impact factor: 9.236

Review 3.  Peptide receptor radionuclide therapy using radiolabeled somatostatin analogs: focus on future developments.

Authors:  Sander M Bison; Mark W Konijnenberg; Marleen Melis; Stefan E Pool; Monique R Bernsen; Jaap J M Teunissen; Dik J Kwekkeboom; Marion de Jong
Journal:  Clin Transl Imaging       Date:  2014-03-05

Review 4.  68Ga-DOTA and analogs: Current status and future perspectives.

Authors:  Krzysztof Kilian
Journal:  Rep Pract Oncol Radiother       Date:  2014-05-19

5.  A new automated NaCl based robust method for routine production of gallium-68 labeled peptides.

Authors:  Michael K Schultz; Dirk Mueller; Richard P Baum; G Leonard Watkins; Wouter A P Breeman
Journal:  Appl Radiat Isot       Date:  2012-08-31       Impact factor: 1.513

6.  First-In-Human Study Demonstrating Tumor-Angiogenesis by PET/CT Imaging with (68)Ga-NODAGA-THERANOST, a High-Affinity Peptidomimetic for αvβ3 Integrin Receptor Targeting.

Authors:  Richard P Baum; Harshad R Kulkarni; Dirk Müller; Stanley Satz; Narasimhan Danthi; Young-Seung Kim; Martin W Brechbiel
Journal:  Cancer Biother Radiopharm       Date:  2015-05       Impact factor: 3.099

7.  Tumor Targeting via Sialic Acid: [68Ga]DOTA-en-pba as a New Tool for Molecular Imaging of Cancer with PET.

Authors:  Charalambos Tsoukalas; Simonetta Geninatti-Crich; Anastasios Gaitanis; Theodoros Tsotakos; Maria Paravatou-Petsotas; Silvio Aime; Rogelio Jiménez-Juárez; Constantinos D Anagnostopoulos; Kristina Djanashvili; Penelope Bouziotis
Journal:  Mol Imaging Biol       Date:  2018-10       Impact factor: 3.488

8.  Triazole Appending Agent (TAAG): A New Synthon for Preparing Iodine-Based Molecular Imaging and Radiotherapy Agents.

Authors:  Alla Darwish; Megan Blacker; Nancy Janzen; Stephanie M Rathmann; Shannon Czorny; Shawn M Hillier; John L Joyal; John W Babich; John F Valliant
Journal:  ACS Med Chem Lett       Date:  2012-02-18       Impact factor: 4.345

9.  Inorganic chemistry in nuclear imaging and radiotherapy: current and future directions.

Authors:  Valerie Carroll; Dustin W Demoin; Timothy J Hoffman; Silvia S Jurisson
Journal:  Radiochim Acta       Date:  2012-08       Impact factor: 1.440

Review 10.  Clinical applications of Gallium-68.

Authors:  Sangeeta Ray Banerjee; Martin G Pomper
Journal:  Appl Radiat Isot       Date:  2013-02-20       Impact factor: 1.513
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.